Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix-Polio pertussis booster immunogenicity study in children, young adults, and elderly
2016-003678-42Phase 4Completed
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Boostrix Polio in pertussis (4 arms), sponsored by National Institute for Public Health and the Environment. Started Jun 2017; status: completed.
02
Drugs
Boostrix Polio
03
Conditions
pertussis
Beyond the preview
Go deeper on 2016-003678-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003678-42.